Iqvia launches patient portal that provides trial participants with study updates, outcomes

By Melissa Fassbender contact

- Last updated on GMT

(Image: Getty/Poike)
(Image: Getty/Poike)

Related tags: IQVIA, Clinical trial

Iqvia today launches its new patient portal, designed to support clinical trial participants throughout the process with a “direct connection to the clinical research environment,” says company executive.

The company in September 2018 expanded its Salesforce alliance​, with plans to develop Software as a Service (SaaS) and technology-enabled services to automate clinical trial processes and ease patient burden.

Today, Iqvia has announced the release of its new Patient Portal, a global web-based solution built on the Salesforce Health Cloud platform. The portal is available as part of its full-service clinical trial offering or as a stand-alone solution.

“In today’s consumer-centric health care environment, patients expect transparency and collaboration from their participation in clinical research,”​ said Cynthia Verst, president, Design and Delivery Innovation, Research and Development Solutions at Iqvia.

Clinical trial participants will be invited to join the portal following recruitment and will receive site visit and medication reminders throughout the study, in addition to travel support services. As approved by the sponsors and investigator, patients also will be able to access their lab results and other information relating to the study.

“In collaboration with the site, the sponsor determines how and when medical data is delivered, ensuring patients get the value of seeing their personal benchmarks after the investigator provides meaningful context and without risk of biasing trial results,”​ Verst told us.

The portal also was designed to comply with upcoming regulations from the EU Directive to provide patients with plain language summaries, and from the US Food and Drug Administration (FDA) to give patient experience data to patients when a trial is completed.

Iqvia recently conducted a patient community survey, which Verst said found patients “are no longer satisfied to be passive participants in the trial experience.”

Per the survey, almost all (89%) reported wanting to have access to their own trial data if they were to participate in clinical research, as well as updates about upcoming clinical trials (81%) and study statistics (78%). Just over half (52%) also said they would like reminders and calendar tools to make participation easier.

“In response to this gap in the marketplace, Iqvia created the Patient Portal designed to make patient access and engagement much easier to deliver,”​ explained Verst.

“The Iqvia Patient Portal takes a human-centered design approach to patient recruitment and retention by giving patients a direct connection to the clinical research environment — and the sponsors hosting these trials.”

Related news

Show more

Related products

RACE Act Prompts Pediatric Oncology Trials

RACE Act Prompts Pediatric Oncology Trials

PRA Health Sciences | 04-May-2020 | Technical / White Paper

Many providers prescribe drugs off-label to pediatric patients, even though there have been few pediatric trials for many of these drugs. In response,...

Global Clinical Trial Lab Services

Global Clinical Trial Lab Services

Q2 Solutions | 01-Apr-2020 | Product Presentation

As a leading global lab services partner, we provide operational excellence, scientific leadership and innovation through technology. We offer end-to-end...

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 01-Mar-2020 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

What do big pharma companies spend on R&D?

What do big pharma companies spend on R&D?

Zymewire | 15-Aug-2019 | Technical / White Paper

The free Big Pharma R&D Spend report examines the financial performance and research & development investments of the top 25 pharmaceutical companies...

Related suppliers

Follow us


View more